Targeted therapy for advanced gastric cancer: A review of current status and future prospects


Kanat O., O'Neil B., Shahda S.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, vol.7, no.12, pp.401-410, 2015 (SCI-Expanded) identifier identifier

Abstract

In the West in particular, the vast majority of gastric cancer (GC) patients present with advanced-stage disease. Although combination chemotherapy is still the most important component of treatment for these patients, it confers a modest survival advantage. Recently, increased knowledge of the key molecular signaling pathways involved in gastric carcinogenesis has led to the discovery of specific molecular-targeted thera-peutic agents. Some of these agents such as trastuzumab and ramucirumab have changed the treatment paradigm for this disease. In this paper, we will summarize the current clinical status of targeted drug therapy in the management of GC.